Fimbriae—Mediated Adherence Induces Cosal Inflammation and Bacterial Clearance

Consequences for Anti-Adhesion Theraphy
  • Hugh Connell
  • William Agace
  • Maria Hedlund
  • Per Klemm
  • Mark Shembri
  • Catharina Svanborg
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 408)


Escherichia colistrains express a variety of fimbrial and non-fimbrial adherence factors which bind via lectin-receptor interactions to host cell glycoconjugate receptors. The attached state provides several advantages; it allows bacteria to resist elimination by the flow of secretions, it enhances their ability to trap nutrients, to multiply and to colonize the mucosa. Attachment may indeed be the endpoint for microbes that form part of the indigenous flora at different mucosal sites. For the pathogens however, adherence is only the first step in a complex series of events that lead to disease. The pathogens may activate the mucosal cells to which they bind, may invade into and through those cells, and may disrupt the integrity of the mucosal cell layer to reach underlying tissue compartments. Common to these events is the induction of an inflammatory response in the mucosa.


A498 Cell Cytokine Response Acute Pyelonephritis Acute Cystitis Bacterial Persistence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abraham, S., Babu, J, Giampapa, C., Hasty, D., Simpson, W., and Beachey, E. (1985) Infect. Immun. 48, 625–628PubMedGoogle Scholar
  2. Agace, W., Hedges, S., Ceska, M., and Svanborg, C. (1993) J. Clin Invest. 92, 780–785PubMedCrossRefGoogle Scholar
  3. Anderson, P., Engberg, I., Lidin-Janson, G., Lincoln, K., Hull, R.,Hull, S. and Svanborg-Edén, C. (1991) Infect. Immun. 59, 2915–2921Google Scholar
  4. Aronson, M., Medalia, O., Schori, L., Mirelman, D., Sharon, N., and Ofek, I. (1979) J. Infect. Diseas. 139, 329–332CrossRefGoogle Scholar
  5. Bar-Shavit, Z., Ofek, I., Goldman, R., Mirelman, D., and Sharon, N. (1977) Biochem. Biophys. Res. Commun. 78, 455–460PubMedCrossRefGoogle Scholar
  6. Bock, K., Breimer, M., Bringole, A., Hansson, G., Karlsson, K-A., Larsson, G., Leffler, H., Samuelsson, B., Strömberg, N., Svanborg-Edén, C., and Thurin, J. (1985) J. Biol. Chem. 260:8545–8551PubMedGoogle Scholar
  7. de Man, R, van Kooten, C., Aarden, L., Engberg, I., and Svanborg-Edén, C. (1989) Infect. Immun. 57:3383–3388PubMedGoogle Scholar
  8. Dobrowsky, R., and Hannun, Y. (1993) Adv. Lipid Res. 25:91–104PubMedGoogle Scholar
  9. Duguid, J., Smith, I., Dempster, G., and Edmunds, P. (1955) J. Path. Bact. 70, 335–348PubMedCrossRefGoogle Scholar
  10. Giampapa C, Abraham S, Chiang T, and Beachey E. (1988) J Biol. Chem. 263, 5362–5367Google Scholar
  11. Hagberg, L., Jodal, U., Korhonen, T., Lidin-Janson, G., Lindberg, U., and Svanborg-Edén, C. (1981) Infect. Immun. 31, 564–570PubMedGoogle Scholar
  12. Hagberg, L., Hull, R., Hull, S., Falkow, S., Freter, R., and Svanborg-Edén, C. (1983) Infect. Immun. 40, 265–272PubMedGoogle Scholar
  13. Hedges, S., Svensson, M., and Svanborg, C. (1992) Infect. Immun. 60:1295–1301PubMedGoogle Scholar
  14. Hedges, S, Agace, W., and Svanborg, C. (1995) Trends in Microbiology. 3. 266–270PubMedCrossRefGoogle Scholar
  15. Hedlund, M, Svensson, M., Nilsson, Å., Duan, R-D, and Svanborg, C. (1996) J. Exp. Med183:in pressGoogle Scholar
  16. Hultgren, S, Porter, T, Schaeffer, A, and Duncan, J. (1985) Infect. Immun. 50, 370–377PubMedGoogle Scholar
  17. Iwahi, T., Abe, Y., Imada, A., and K. Tsuchiya. (1983) Infect. Immun. 39, 1307–1315PubMedGoogle Scholar
  18. Johnson, J. (1991) Clin. Microbial. Rev. 4, 80–128Google Scholar
  19. Joseph, C., Wright, S., Bornmann, W., Randolph, J., Kumar, E., Bittman, R., Liu, J., and Kolesnick, R. (1994) J. Biol. Chem. 269:17606–17610PubMedGoogle Scholar
  20. Keith, B., Maurer, L., Spears, P., and Orndorff, P. (1986) Infect. Immun. 53, 693–696PubMedGoogle Scholar
  21. Klemm, P., JØrgensen, B., van Die, I., de Ree, H., and Bergmans, H. (1985) Mol. Gen. Genet. 199, 410–414PubMedCrossRefGoogle Scholar
  22. Klemm, P., and Krogfelt, K. (1994) in Fimbriae; Adhesion, Genetics, Biogenesis, and Vaccinesed. Klemm, P. (CRC Press, Boca Raton), pp. 9–26Google Scholar
  23. Krogfelt, K., Bergmans, H., and Klemm, P. (1990) Infect. Immun. 58, 1995–1998PubMedGoogle Scholar
  24. Leffler, H., and Svanborg-Edén, C. (1980) FEMS Lett. 8:127–134CrossRefGoogle Scholar
  25. Linder, H., Engberg, I., Mattsby-Baltzer, I., Jann, K., and Svanborg-Edén, C. (1988) Infect. Immun56:1039- 1313Google Scholar
  26. Linder, H., Engberg, I., Hoschüttzky, H., Mattsby-Baltzer, I., and Svanborg, C. (1991) infect. Immun. 59:4357–4362Google Scholar
  27. Malaviya, R., Ross, E., Jakschik, B., and Abraham, S. (1994) J. Clin Invest. 93, 1645–1653PubMedCrossRefGoogle Scholar
  28. Mårild, S., Jodal, U., Ørskov, I., Ørskov, F., Svanborg Edén, C. (1989) J. Pediatr. 115, 40–45PubMedCrossRefGoogle Scholar
  29. Mathias, S., Dressler, K., and Kolesnick, R. (1991) Proc. Natl. Acad. Sci. USA. 88:10009–10013PubMedCrossRefGoogle Scholar
  30. Mathias, S., Younes, A., Kan, C., Orlow, I., Joseph, C., and Kolesnick, R. (1993) Science (Wash DC)259:519–522CrossRefGoogle Scholar
  31. Ofek, I., Mirelman, D., and Sharon, N. (1977) Nature (London). 265, 623–625CrossRefGoogle Scholar
  32. Ponniah, S., Abraham, S., Docktor, M., Wall, C., and Endres, R. (1989) J. Immunol. 142, 992–998PubMedGoogle Scholar
  33. Ponniah, S., Abraham, S., and Endres, R. (1992) Infect. Immun. 60, 5197–5203PubMedGoogle Scholar
  34. Roberts, J. Marklund, B., liver, D., Haslam, D., Kaak, M., Baskin, B., Louis, M., Möllby, R., Winberg, K., and Normark, S. (1995) Proc. Natl. Acad. Sci. 91, 11889–11893CrossRefGoogle Scholar
  35. Schütze, S., Potthoff, K., Machleidt, T., Berkovic, C., Wiegman, K., and Krönke, M. (1992) Cell71:765–776PubMedCrossRefGoogle Scholar
  36. Sharon, N., and Ofek, I. (1986) In Microbial lectins and agglutinins: properties and biological activity, ed. Mirelman, D. (Wiley and sons. New York), pp. 55–82Google Scholar
  37. Silverblatt, F., and Cohen, L. (1979) J. Clin. Invest. 64, 333–336PubMedCrossRefGoogle Scholar
  38. Sokurenko, E., Courtney, H., Ohman, D., Klemm, P., and Hasty, D. (1994) J. Bacteriol. 176, 748–755PubMedGoogle Scholar
  39. Sokurenko, E., Courtney, H., Maslow, J., Siitonen, A., and Hasty, D. (1995) J. Bacteriol(In press).Google Scholar
  40. Steadman, R., Topley, N., Jenner, D. E., Davies, M., and Williams, J. (1988) Infect Immun. 56, 815–822PubMedGoogle Scholar
  41. Svanborg, C., Ørskov, F., and Ørskov, I. (1994) in Fimbriae; Adhesion, Genetics, Biogenesis, and Vaccinesed. Klemm, P. (CRC Press, Boca Raton), pp. 239–254Google Scholar
  42. Tewari, R., MacGregor, J., Ikeda, T., Little, R., Hultgren, S., and Abraham, S. (1993) J. Biol Chem. 268, 3009–3015PubMedGoogle Scholar
  43. Wold, A., Mestecky, J., Tomana, M., Kobata, A., Ohbayashi, H., Endo, T., and Svanborg-Edén, C. (1990) Infect. Immun. 58, 3073–3077PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • Hugh Connell
    • 1
  • William Agace
    • 1
  • Maria Hedlund
    • 1
  • Per Klemm
    • 2
  • Mark Shembri
    • 2
  • Catharina Svanborg
    • 1
  1. 1.Department of Medical Microbiology, Section of Clinical ImmunologyLund UniversityLundSweden
  2. 2.Department of MicrobiologyThe Technical University of DenmarkLyngbyDenmark

Personalised recommendations